CA 125 and other tumor markers in uterine leiomyomas and their association with lesion characteristics.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Clinical and Experimental Medicine

• Publication date

  2014-04-15

• Fields of study

  Medicine

• Identifiers
  PMID 24955185PMCID PMC4057864
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers in uterine leiomyoma.

  2013cited by this paper
• Methodological and analytic considerations for blood biomarkers.

  2012cited by this paper
• Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders.

  2012cited by this paper
• Dramatic changes of CA 125 levels in a pregnant woman with a degenerated subserosal myoma.

  2012cited by this paper
• Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis.

  2012cited by this paper
• New Directions in the Epidemiology of Uterine Fibroids

  2010cited by this paper
• Assessment of the predictivity of preoperative serum CA 125 in the differential diagnosis of uterine leiomyoma and uterine sarcoma in the Turkish female population.

  2009cited by this paper
• Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review.

  2009cited by this paper
• Elevation of CA 19‐9 and chromogranin A, in addition to CA 125, are detectable in benign tumors in leiomyomas and endometriosis

  2007cited by this paper
• Serum leptin levels in women with uterine leiomyomas.

  2007cited by this paper
• High levels of CA125 (over 1,000 IU/ml) in patients with gynecologic disease and no malignant conditions: three cases and literature review

  2007cited by this paper
• Serum CA-125 Levels in Women with Uterine Leiomyomata And A Review of The Literature

  2007cited by this paper
• Potential role of preoperative serum CA125 for the differential diagnosis between uterine leiomyoma and uterine leiomyosarcoma.

  2006cited by this paper
• New tumor markers: CA125 and beyond

  2005cited by this paper
• Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study.

  2004cited by this paper
• Laparoscopic bipolar coagulation of uterine vessels to treat symptomatic myomas in women with elevated Ca 125.

  2001cited by this paper
• [The value of serum CA125 assays in the diagnosis of uterine adenomyosis].

  1996cited by this paper
• Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas.

  1994cited by this paper
• Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues.

  1993cited by this paper
• Peripheral CA 125 levels in patients with uterine fibroids.

  1992cited by this paper
• The effect of hysterectomy on serum CA 125 levels in patients with adenomyosis and uterine fibroids.

  1987cited by this paper
• [Differential diagnosis between leiomyomata uteri and adenomyosis using CA 125 as a new tumor marker of ovarian carcinoma].

  1985cited by this paper
• [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].

  1984cited by this paper

• Preoperative Considerations for Uterine Fibroid Removal in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome and Klippel-Feil Syndrome: A Case Report

  2026cites this paper
• AMH and Kisspeptin Receptor Expression in Rare Hydropic Leiomyoma: A Case Study

  2025cites this paper
• Complete Cystic Degeneration of a Uterine Myoma Posing a Diagnostic Dilemma

  2025cites this paper
• Prognosis of premenopausal women with low-risk endometrial cancer but elevated CA125 levels

  2025cites this paper
• Cystic degeneration of a fibroid in the context of abnormal uterine bleeding in young patients: a case report

  2025cites this paper
• CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations

  2025cites this paper
• Circulating biomarkers for the preoperative diagnosis of uterine sarcoma: A systematic review and meta-analysis.

  2025cites this paper
• Crimson clues: advancing endometriosis detection and management with novel blood biomarkers.

  2024cites this paper
• Evaluating CA-125 and PET/CT for cancer detection in idiopathic inflammatory myopathies.

  2024cites this paper
• The Impact of Adenomyosis on Pregnancy

  2024cites this paper
• Value of serum muscular creatinine phosphokinase levels in patients with adenomyosis as a non‐invasive diagnostic marker

  2024cites this paper
• Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location

  2024cites this paper
• Diagnostic Accuracy of CA 19-9 in Ovarian Malignancy

  2024cites this paper
• Hydropic leiomyoma-like ovarian tumor: a case report

  2024cites this paper
• Notes on the morphological features of cotyledonary dissecting leiomyoma, which is rare in clinical practice

  2023cites this paper
• Diagnostic Challenge: Distinguishing Uterine Fibroid with Cystic Degeneration vs. Ovarian Cystic Malignancy. A Case Report.

  2023cites this paper
• Stroke in Patients With Common Noncancerous Gynecologic Diseases: A Multicenter Study in Japan.

  2023cites this paper
• Importance of diagnostic methods for round ligament leiomyomas in clinical practice

  2023cites this paper
• Unsuspected Low Grade Endometrial Stromal Sarcoma-Clues to Improve Preoperative Diagnosis

  2022cites this paper
• Utilization of Pelvic Ultrasonography and CA125 Level to Diagnose Uterine Myoma and Adenomyosis

  2022influential citation
• Retroperitoneal Hydropic Leiomyoma Mimicking an Ovarian Cyst

  2022cites this paper
• Uterine Embolization as a New Treatment Option in Adenomyosis Uteri

  2021cites this paper
• Evaluation of Biomarkers in Myoma Patients: A Prospective Study Investigating the Role of LDH, CA 125, and IGF-1 after Uterus-Preserving Surgical Therapy

  2021cites this paper
• Abdominopelvic leiomyoma with large ascites: A case report and review of the literature

  2021cites this paper
• The Clinical Features and Diagnosis of Adenomyosis

  2021cites this paper
• Advanced leiomyosarcoma of the uterus: a case report and literature review

  2021cites this paper
• An enormous pelvic tumor in a 46-year-old woman with an elevated serum CA 125 level, what lies beneath it? Investigation of uterine tumors in postmenopausal women

  2021cites this paper
• Extensive Metastatic Leiomyosarcoma to Multiple Abdominal Organs from a Prior Uterine High Grade Leiomyosarcoma. Report of a Case and Review of the Literature

  2021cites this paper
• Pregnancy-related leiomyoma growth and pregnancy complications in pregnant women after IVF

  2020cites this paper
• Developing a Preoperative Algorithm for the Diagnosis of Uterine Leiomyosarcoma

  2020cites this paper
• Vaginal leiomyoma: medical imaging and diagnosis in a resource low tertiary hospital: case report

  2020cites this paper
• Abdominopelvic leiomyoma with large ascites: a case report and literature review

  2020cites this paper
• How to differentiate uterine leiomyosarcoma from leiomyoma with imaging.

  2019cites this paper
• Role of Tumor Markers

  2019cites this paper
• Identification of a novel diagnostic gene expression signature to discriminate uterine leiomyoma from leiomyosarcoma.

  2019cites this paper
• Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases

  2018cites this paper
• ABNORMALLY RAISED CA125 IN A PATIENT OF LUMP IN ABDOMEN, DILEMMA IN DIAGNOSIS

  2017cites this paper
• Uterine fibroids with positive 18F-FDG PET/CT image and significantly increased CA19-9

  2017influential citation
• Prédictibilité préopératoire de la malignité des tumeurs ovariennes à partir du score ADNEX et utilisation en pratique clinique

  2016cites this paper
• Preoperative evaluation in women with uterine leiomyosarcoma. A nationwide cohort study

  2016cites this paper
• [Before surgery predictability of malignant ovarian tumors based on ADNEX model and its use in clinical practice].

  2016cites this paper
• High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms

  2016cites this paper
• Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings

  2016cites this paper
• Uterine fibroids: Investigation 
and current management trends.

  2016cites this paper
• Highly Elevated Level of Serum CA125 Produced by a Large Uterine Leiomyoma in a 20-Year-Old Woman

  2015cites this paper
• Micro Abscess Formation in Adenomyotic Focus, a Rare Case

  2015cites this paper
• Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma.

  2015cites this paper
• Clinical application and prognostic assessment of serum Tumor Associated Material (TAM) from esophageal cancer patients.

  2014cites this paper